Dose Characterization of the Investigational Anticancer Drug Tigilanol Tiglate (EBC-46) in the Local Treatment of Canine Mast Cell Tumors

Overview of attention for article published in Frontiers in Veterinary Science, April 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (67th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

So far, Dimensions has found 29 publications that cite this research output.

Article in Frontiers in Immunology (March 2024)

Article in Journal of Oral Microbiology (July 2023)

Article in Vlaams Diergeneeskundig Tijdschrift (April 2023)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.